UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment

Annals of oncology, 2011-03, Vol.22 (3), p.515-523

2011

Volltextzugriff (PDF)

Biomarker results from the AVADO phase 3 trial of first-line bevacizumab plus docetaxel for HER2-negative metastatic breast cancer

British journal of cancer, 2013-03, Vol.108 (5), p.1052-1060

2013

Volltextzugriff (PDF)

Infiltrating stromal immune cells in inflammatory breast cancer are associated with an improved outcome and increased PD-L1 expression

Breast cancer research : BCR, 2019-02, Vol.21 (1), p.28-28, Article 28

2019

Volltextzugriff (PDF)

Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting

British journal of cancer, 2013-04, Vol.108 (6), p.1358-1367

2013

Volltextzugriff (PDF)

Impact of age on breast cancer mortality and competing causes of death at 10 years follow-up in the adjuvant TEAM trial

European journal of cancer (1990), 2018-08, Vol.99, p.1-8

2018

Volltextzugriff (PDF)

Long‐term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30‐month analysis of the randomized phase 2 BOLT study

Journal of the European Academy of Dermatology and Venereology, 2018-03, Vol.32 (3), p.372-381

2018

Volltextzugriff (PDF)

A randomized adaptive phase II/III study of buparlisib, a pan-class I PI3K inhibitor, combined with paclitaxel for the treatment of HER2– advanced breast cancer (BELLE-4)

Annals of oncology, 2017-02, Vol.28 (2), p.313-320

2017

Volltextzugriff (PDF)

Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel

Annals of oncology, 2008-03, Vol.19 (3), p.420-432

2008

Volltextzugriff (PDF)

Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19 mammaglobin RT-PCR in patients with metastatic breast cancer

British journal of cancer, 2010-01, Vol.102 (2), p.276-284

2010

Volltextzugriff (PDF)

Integrated miRNA and mRNA expression profiling of the inflammatory breast cancer subtype

British journal of cancer, 2010-08, Vol.103 (4), p.532-541

2010

Volltextzugriff (PDF)

Role of combination therapy with aromatase and cyclooxygenase-2 inhibitors in patients with metastatic breast cancer

Annals of oncology, 2009-04, Vol.20 (4), p.615-620

2009

Volltextzugriff (PDF)

Detection and prognostic significance of circulating tumour cells in patients with metastatic breast cancer according to immunohistochemical subtypes

British journal of cancer, 2014-01, Vol.110 (2), p.375-383

2014

Volltextzugriff (PDF)

Safety and efficacy of neratinib (HKI-272) plus vinorelbine in the treatment of patients with ErbB2-positive metastatic breast cancer pretreated with anti-HER2 therapy

Annals of oncology, 2013-01, Vol.24 (1), p.109-116

2013

Volltextzugriff (PDF)

Real-time RT-PCR detection of disseminated tumour cells in bone marrow has superior prognostic significance in comparison with circulating tumour cells in patients with breast cancer

British journal of cancer, 2006-03, Vol.94 (5), p.672-680

2006

Volltextzugriff (PDF)

Gene expression profiles in circulating tumor cells to predict prognosis in metastatic breast cancer patients

Annals of oncology, 2015-03, Vol.26 (3), p.510-516

2015

Volltextzugriff (PDF)

Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse

Annals of oncology, 2001-02, Vol.12 (2), p.259-266

2001

Volltextzugriff (PDF)

Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer

British journal of cancer, 2002-02, Vol.86 (3), p.389-395

2002

Volltextzugriff (PDF)

Gene expression profiles of inflammatory breast cancer: correlation with response to neoadjuvant chemotherapy and metastasis-free survival

Annals of oncology, 2014-02, Vol.25 (2), p.358-365

2014

Volltextzugriff (PDF)

An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer

Annals of oncology, 2010-02, Vol.21 (2), p.275-282

2010

Volltextzugriff (PDF)

Dynamic prediction in breast cancer: proving feasibility in clinical practice using the TEAM trial

Annals of oncology, 2015-06, Vol.26 (6), p.1254-1262

2015

Volltextzugriff (PDF)

The presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patients

British journal of cancer, 2009-04, Vol.100 (8), p.1277-1286

2009

Volltextzugriff (PDF)

Distinguishing blood and lymph vessel invasion in breast cancer: a prospective immunohistochemical study

British journal of cancer, 2006-06, Vol.94 (11), p.1643-1649

2006

Volltextzugriff (PDF)

The VEGF pathway and the AKT mTOR p70S6K1 signalling pathway in human epithelial ovarian cancer

British journal of cancer, 2009-03, Vol.100 (6), p.971-978

2009

Volltextzugriff (PDF)

A phase II study of the combination of endocrine treatment and bortezomib in patients with endocrine-resistant metastatic breast cancer

Oncology reports, 2012-03, Vol.27 (3), p.657-663

2012

Volltextzugriff (PDF)

A fibrotic focus is a prognostic factor and a surrogate marker for hypoxia and (lymph)angiogenesis in breast cancer: review of the literature and proposal on the criteria of evaluation

Histopathology, 2007-10, Vol.51 (4), p.440-451

2007

Volltextzugriff (PDF)

1 – 25 von 160

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(153)
Mit Volltextzugriff
(151)

Publikationsform

Artikel
(160)

Sprache

Englisch
(159)
Niederländisch
(1)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment

Biomarker results from the AVADO phase 3 trial of first-line bevacizumab plus docetaxel for HER2-negative metastatic breast cancer

Infiltrating stromal immune cells in inflammatory breast cancer are associated with an improved outcome and increased PD-L1 expression

Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting

Impact of age on breast cancer mortality and competing causes of death at 10 years follow-up in the adjuvant TEAM trial

Long‐term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30‐month analysis of the randomized phase 2 BOLT study

A randomized adaptive phase II/III study of buparlisib, a pan-class I PI3K inhibitor, combined with paclitaxel for the treatment of HER2– advanced breast cancer (BELLE-4)

Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel

Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19 mammaglobin RT-PCR in patients with metastatic breast cancer

Integrated miRNA and mRNA expression profiling of the inflammatory breast cancer subtype

Role of combination therapy with aromatase and cyclooxygenase-2 inhibitors in patients with metastatic breast cancer

Detection and prognostic significance of circulating tumour cells in patients with metastatic breast cancer according to immunohistochemical subtypes

Safety and efficacy of neratinib (HKI-272) plus vinorelbine in the treatment of patients with ErbB2-positive metastatic breast cancer pretreated with anti-HER2 therapy

Real-time RT-PCR detection of disseminated tumour cells in bone marrow has superior prognostic significance in comparison with circulating tumour cells in patients with breast cancer

Gene expression profiles in circulating tumor cells to predict prognosis in metastatic breast cancer patients

Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse

Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer

Gene expression profiles of inflammatory breast cancer: correlation with response to neoadjuvant chemotherapy and metastasis-free survival

An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer

Dynamic prediction in breast cancer: proving feasibility in clinical practice using the TEAM trial

The presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patients

Distinguishing blood and lymph vessel invasion in breast cancer: a prospective immunohistochemical study

The VEGF pathway and the AKT mTOR p70S6K1 signalling pathway in human epithelial ovarian cancer

A phase II study of the combination of endocrine treatment and bortezomib in patients with endocrine-resistant metastatic breast cancer

A fibrotic focus is a prognostic factor and a surrogate marker for hypoxia and (lymph)angiogenesis in breast cancer: review of the literature and proposal on the criteria of evaluation

Aktive Filter

Suchergebnisse filtern